Roche (VTX:ROG) received a CHF 230 target price from investment analysts at Morgan Stanley in a research note issued to investors on Tuesday. The firm presently has a “sell” rating on the healthcare company’s stock. Morgan Stanley’s target price would indicate a potential upside of 4.74% from the company’s previous close.

A number of other analysts also recently commented on ROG. Barclays set a CHF 305 price objective on shares of Roche and gave the company a “buy” rating in a report on Wednesday, December 27th. DZ Bank set a CHF 270 price objective on shares of Roche and gave the company a “buy” rating in a report on Friday, February 2nd. Goldman Sachs set a CHF 300 price objective on shares of Roche and gave the company a “buy” rating in a report on Friday, March 2nd. Jefferies Group set a CHF 290 price objective on shares of Roche and gave the company a “buy” rating in a report on Monday, February 26th. Finally, JPMorgan Chase set a CHF 300 price objective on shares of Roche and gave the company a “buy” rating in a report on Friday. Five equities research analysts have rated the stock with a sell rating, six have issued a hold rating and ten have assigned a buy rating to the company. Roche presently has an average rating of “Hold” and an average price target of CHF 253.30.

How to Become a New Pot Stock Millionaire

Roche stock traded down CHF 1.20 during midday trading on Tuesday, reaching CHF 219.60. The company had a trading volume of 3,740,000 shares, compared to its average volume of 2,090,000. Roche has a 12-month low of CHF 214.30 and a 12-month high of CHF 273.

ILLEGAL ACTIVITY WARNING: This piece of content was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2018/04/17/roche-rog-given-a-chf-230-price-target-by-morgan-stanley-analysts.html.

Roche Company Profile

Rogers Corporation designs, develops, manufactures, and sells engineered materials and components worldwide. The company's Advanced Connectivity Solutions segment offers circuit materials and solutions for connectivity applications in wireless communications infrastructure, automotive, connected devices, wired infrastructure, consumer electronics, and aerospace/defense.

Analyst Recommendations for Roche (VTX:ROG)

Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.